Click here to get full coverage on FDA sets June 27 action date for Unicycive kidney disease pill - Stock Titan

FDA sets June 27 action date for Unicycive kidney disease pill  Stock Titan

FDA sets June 27 action date for Unicycive kidney disease pill - Stock Titan

Click here to get full coverage on Unicycive Therapeutics, Inc. (UNCY) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Stockholders to Contact the Firm to Learn More About the Investigation - ACCESS Newswire

Unicycive Therapeutics, Inc. (UNCY) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Stockholders to Contact the Firm to Learn More About the Investigation  ACCESS Newswire

Unicycive Therapeutics, Inc. (UNCY) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Stockholders to Contact the Firm to Learn More About the Investigation - ACCESS Newswire

Click here to get full coverage on Companies Like Unicycive Therapeutics (NASDAQ:UNCY) Are In A Position To Invest In Growth - Yahoo Finance

Companies Like Unicycive Therapeutics (NASDAQ:UNCY) Are In A Position To Invest In Growth  Yahoo Finance

Companies Like Unicycive Therapeutics (NASDAQ:UNCY) Are In A Position To Invest In Growth - Yahoo Finance

Click here to get full coverage on Important Notice to Long-Term Shareholders of Integer - GlobeNewswire

Important Notice to Long-Term Shareholders of Integer  GlobeNewswire

Important Notice to Long-Term Shareholders of Integer - GlobeNewswire

Click here to get full coverage on We Might See A Profit From Unicycive Therapeutics, Inc. (NASDAQ:UNCY) Soon - simplywall.st

We Might See A Profit From Unicycive Therapeutics, Inc. (NASDAQ:UNCY) Soon  simplywall.st

We Might See A Profit From Unicycive Therapeutics, Inc. (NASDAQ:UNCY) Soon - simplywall.st

Click here to get full coverage on Unicycive’s Kidney Drug Pipeline Puts A Small Stock On The Clock - Finimize

Unicycive’s Kidney Drug Pipeline Puts A Small Stock On The Clock  Finimize

Unicycive’s Kidney Drug Pipeline Puts A Small Stock On The Clock - Finimize

Click here to get full coverage on New Analyst Forecast: $UNCY Given 'Speculative Buy' Rating | UNCY Stock News - Quiver Quantitative

New Analyst Forecast: $UNCY Given 'Speculative Buy' Rating | UNCY Stock News  Quiver Quantitative

New Analyst Forecast: $UNCY Given 'Speculative Buy' Rating | UNCY Stock News - Quiver Quantitative

Click here to get full coverage on Kuehn Law Encourages Investors of Unicycive Therapeutics, Inc. to Contact Law Firm - TMX Newsfile

Kuehn Law Encourages Investors of Unicycive Therapeutics, Inc. to Contact Law Firm  TMX Newsfile

Kuehn Law Encourages Investors of Unicycive Therapeutics, Inc. to Contact Law Firm - TMX Newsfile

Click here to get full coverage on UNCY Deadline Today: Rosen Law Firm Urges Unicycive Therapeutics, Inc. (NASDAQ: UNCY) Stockholders with Large Losses to Contact the Firm for Information About Their Rights - Business Wire

UNCY Deadline Today: Rosen Law Firm Urges Unicycive Therapeutics, Inc. (NASDAQ: UNCY) Stockholders with Large Losses to Contact the Firm for Information About Their Rights  Business Wire

UNCY Deadline Today: Rosen Law Firm Urges Unicycive Therapeutics, Inc. (NASDAQ: UNCY) Stockholders with Large Losses to Contact the Firm for Information About Their Rights - Business Wire

Click here to get full coverage on Retail investors who hold 48% of Unicycive Therapeutics, Inc. (NASDAQ:UNCY) gained 23%, institutions profited as well - Yahoo Finance

Retail investors who hold 48% of Unicycive Therapeutics, Inc. (NASDAQ:UNCY) gained 23%, institutions profited as well  Yahoo Finance

Retail investors who hold 48% of Unicycive Therapeutics, Inc. (NASDAQ:UNCY) gained 23%, institutions profited as well - Yahoo Finance

Click here to get full coverage on Unicycive (NASDAQ: UNCY) reports 7x lower pill volume, 2x fewer pills with OLC - Stock Titan

Unicycive (NASDAQ: UNCY) reports 7x lower pill volume, 2x fewer pills with OLC  Stock Titan

Unicycive (NASDAQ: UNCY) reports 7x lower pill volume, 2x fewer pills with OLC - Stock Titan

Click here to get full coverage on Unicycive Therapeutics (NASDAQ:UNCY) Is In A Good Position To Deliver On Growth Plans - simplywall.st

Unicycive Therapeutics (NASDAQ:UNCY) Is In A Good Position To Deliver On Growth Plans  simplywall.st

Unicycive Therapeutics (NASDAQ:UNCY) Is In A Good Position To Deliver On Growth Plans - simplywall.st

Click here to get full coverage on Important Notice to Long-Term Shareholders of Boston - GlobeNewswire

Important Notice to Long-Term Shareholders of Boston  GlobeNewswire

Important Notice to Long-Term Shareholders of Boston - GlobeNewswire

Click here to get full coverage on Unicycive Therapeutics Provides Business Update and Financial Results, Poised to Resubmit NDA for Oxylanthanum Carbonate by Year-End | UNCY Stock News - Quiver Quantitative

Unicycive Therapeutics Provides Business Update and Financial Results, Poised to Resubmit NDA for Oxylanthanum Carbonate by Year-End | UNCY Stock News  Quiver Quantitative

Unicycive Therapeutics Provides Business Update and Financial Results, Poised to Resubmit NDA for Oxylanthanum Carbonate by Year-End | UNCY Stock News - Quiver Quantitative

Click here to get full coverage on Rosen Law Firm Urges Unicycive Therapeutics, Inc. (NASDAQ: UNCY) Stockholders with Large Losses to Contact the Firm for Information About Their Rights - Business Wire

Rosen Law Firm Urges Unicycive Therapeutics, Inc. (NASDAQ: UNCY) Stockholders with Large Losses to Contact the Firm for Information About Their Rights  Business Wire

Rosen Law Firm Urges Unicycive Therapeutics, Inc. (NASDAQ: UNCY) Stockholders with Large Losses to Contact the Firm for Information About Their Rights - Business Wire

Click here to get full coverage on New pill for dialysis patients moves ahead as FDA review restarts - Stock Titan

New pill for dialysis patients moves ahead as FDA review restarts  Stock Titan

New pill for dialysis patients moves ahead as FDA review restarts - Stock Titan

Click here to get full coverage on Is Unicycive Therapeutics (NASDAQ:UNCY) In A Good Position To Invest In Growth? - Yahoo Finance

Is Unicycive Therapeutics (NASDAQ:UNCY) In A Good Position To Invest In Growth?  Yahoo Finance

Is Unicycive Therapeutics (NASDAQ:UNCY) In A Good Position To Invest In Growth? - Yahoo Finance

Click here to get full coverage on Unicycive (NASDAQ: UNCY) targets year-end OLC NDA resubmission; $42M cash into 2027 - Stock Titan

Unicycive (NASDAQ: UNCY) targets year-end OLC NDA resubmission; $42M cash into 2027  Stock Titan

Unicycive (NASDAQ: UNCY) targets year-end OLC NDA resubmission; $42M cash into 2027 - Stock Titan

Click here to get full coverage on HC Wainwright & Co. Maintains Unicycive Therapeutics (UNCY) Buy Recommendation - Nasdaq

HC Wainwright & Co. Maintains Unicycive Therapeutics (UNCY) Buy Recommendation  Nasdaq

HC Wainwright & Co. Maintains Unicycive Therapeutics (UNCY) Buy Recommendation - Nasdaq

Click here to get full coverage on Analysts Expect Breakeven For Unicycive Therapeutics, Inc. (NASDAQ:UNCY) Before Long - Yahoo Finance

Analysts Expect Breakeven For Unicycive Therapeutics, Inc. (NASDAQ:UNCY) Before Long  Yahoo Finance

Analysts Expect Breakeven For Unicycive Therapeutics, Inc. (NASDAQ:UNCY) Before Long - Yahoo Finance

Click here to get full coverage on Retail investors are Unicycive Therapeutics, Inc.'s (NASDAQ:UNCY) biggest owners and were hit after market cap dropped US$28m - Yahoo Finance

Retail investors are Unicycive Therapeutics, Inc.'s (NASDAQ:UNCY) biggest owners and were hit after market cap dropped US$28m  Yahoo Finance

Retail investors are Unicycive Therapeutics, Inc.'s (NASDAQ:UNCY) biggest owners and were hit after market cap dropped US$28m - Yahoo Finance

Click here to get full coverage on Unicycive granted FDA review for resubmitted marketing application for kidney disease drug - Seeking Alpha

Unicycive granted FDA review for resubmitted marketing application for kidney disease drug  Seeking Alpha

Unicycive granted FDA review for resubmitted marketing application for kidney disease drug - Seeking Alpha

Click here to get full coverage on Important Notice to Long-Term Shareholders of Corcept - GlobeNewswire

Important Notice to Long-Term Shareholders of Corcept  GlobeNewswire

Important Notice to Long-Term Shareholders of Corcept - GlobeNewswire

Click here to get full coverage on Unicycive Therapeutics, Inc. (NASDAQ:UNCY) Given Consensus Recommendation of "Moderate Buy" by Analysts - MarketBeat

Unicycive Therapeutics, Inc. (NASDAQ:UNCY) Given Consensus Recommendation of "Moderate Buy" by Analysts  MarketBeat

Unicycive Therapeutics, Inc. (NASDAQ:UNCY) Given Consensus Recommendation of "Moderate Buy" by Analysts - MarketBeat

Click here to get full coverage on Unicycive Therapeutics: Manageable CMC Speed Bump - Pill Burden Edge Intact, Buying (UNCY) - Seeking Alpha

Unicycive Therapeutics: Manageable CMC Speed Bump - Pill Burden Edge Intact, Buying (UNCY)  Seeking Alpha

Unicycive Therapeutics: Manageable CMC Speed Bump - Pill Burden Edge Intact, Buying (UNCY) - Seeking Alpha

Click here to get full coverage on Unicycive Therapeutics Announces Resubmission of New Drug Application (NDA) for Oxylanthanum Carbonate (OLC) - GlobeNewswire

Unicycive Therapeutics Announces Resubmission of New Drug Application (NDA) for Oxylanthanum Carbonate (OLC)  GlobeNewswire

Unicycive Therapeutics Announces Resubmission of New Drug Application (NDA) for Oxylanthanum Carbonate (OLC) - GlobeNewswire

Click here to get full coverage on Unicycive Therapeutics Provides Update on FDA Meeting and NDA Resubmission Timeline for Oxylanthanum Carbonate | UNCY Stock News - Quiver Quantitative

Unicycive Therapeutics Provides Update on FDA Meeting and NDA Resubmission Timeline for Oxylanthanum Carbonate | UNCY Stock News  Quiver Quantitative

Unicycive Therapeutics Provides Update on FDA Meeting and NDA Resubmission Timeline for Oxylanthanum Carbonate | UNCY Stock News - Quiver Quantitative

Click here to get full coverage on Guggenheim reiterates Buy rating on Unicycive stock amid NDA resubmission - Investing.com

Guggenheim reiterates Buy rating on Unicycive stock amid NDA resubmission  Investing.com

Guggenheim reiterates Buy rating on Unicycive stock amid NDA resubmission - Investing.com

Click here to get full coverage on Unicycive Therapeutics (Nasdaq:UNCY) has big plans for its lead candidate OLC - Stocks Down Under

Unicycive Therapeutics (Nasdaq:UNCY) has big plans for its lead candidate OLC  Stocks Down Under

Unicycive Therapeutics (Nasdaq:UNCY) has big plans for its lead candidate OLC - Stocks Down Under

Click here to get full coverage on Guggenheim Initiates Coverage of Unicycive Therapeutics (UNCY) with Buy Recommendation - Nasdaq

Guggenheim Initiates Coverage of Unicycive Therapeutics (UNCY) with Buy Recommendation  Nasdaq

Guggenheim Initiates Coverage of Unicycive Therapeutics (UNCY) with Buy Recommendation - Nasdaq

Click here to get full coverage on Unicycive: 'Buy' Rating On NDA Resubmission OLC And Potential Best-In-Class Profile - Seeking Alpha

Unicycive: 'Buy' Rating On NDA Resubmission OLC And Potential Best-In-Class Profile  Seeking Alpha

Unicycive: 'Buy' Rating On NDA Resubmission OLC And Potential Best-In-Class Profile - Seeking Alpha

Click here to get full coverage on We Think Unicycive Therapeutics (NASDAQ:UNCY) Needs To Drive Business Growth Carefully - Sahm

We Think Unicycive Therapeutics (NASDAQ:UNCY) Needs To Drive Business Growth Carefully  Sahm

We Think Unicycive Therapeutics (NASDAQ:UNCY) Needs To Drive Business Growth Carefully - Sahm

Click here to get full coverage on Why Is Unicycive Therapeutics Stock (UNCY) Down 35% Today? - TipRanks

Why Is Unicycive Therapeutics Stock (UNCY) Down 35% Today?  TipRanks

Why Is Unicycive Therapeutics Stock (UNCY) Down 35% Today? - TipRanks

Click here to get full coverage on UNCY Stock Price, News & Analysis - Stock Titan

UNCY Stock Price, News & Analysis  Stock Titan

UNCY Stock Price, News & Analysis - Stock Titan

Click here to get full coverage on Unicycive Therapeutics Announces FDA Acceptance of - GlobeNewswire

Unicycive Therapeutics Announces FDA Acceptance of  GlobeNewswire

Unicycive Therapeutics Announces FDA Acceptance of - GlobeNewswire

Click here to get full coverage on Important Notice to Long-Term Shareholders of Five Below, - GlobeNewswire

Important Notice to Long-Term Shareholders of Five Below,  GlobeNewswire

Important Notice to Long-Term Shareholders of Five Below, - GlobeNewswire

Click here to get full coverage on UNCY Stock Drops Amid FDA Manufacturing Deficiencies - GuruFocus

UNCY Stock Drops Amid FDA Manufacturing Deficiencies  GuruFocus

UNCY Stock Drops Amid FDA Manufacturing Deficiencies - GuruFocus

Click here to get full coverage on Unicycive Therapeutics Announces FDA Acceptance Of Oxylanthanum Carbonate (OLC) New Drug Application (NDA) Resubmission - TradingView

Unicycive Therapeutics Announces FDA Acceptance Of Oxylanthanum Carbonate (OLC) New Drug Application (NDA) Resubmission  TradingView

Unicycive Therapeutics Announces FDA Acceptance Of Oxylanthanum Carbonate (OLC) New Drug Application (NDA) Resubmission - TradingView

Click here to get full coverage on FDA to Review Unicycive's Kidney Disease Drug in June 2025: Key Financial Updates - Stock Titan

FDA to Review Unicycive's Kidney Disease Drug in June 2025: Key Financial Updates  Stock Titan

FDA to Review Unicycive's Kidney Disease Drug in June 2025: Key Financial Updates - Stock Titan

Click here to get full coverage on Important Notice to Long-Term Shareholders of Cytokinetics, - GlobeNewswire

Important Notice to Long-Term Shareholders of Cytokinetics,  GlobeNewswire

Important Notice to Long-Term Shareholders of Cytokinetics, - GlobeNewswire

Click here to get full coverage on Unicycive Therapeutics, Inc. Sued for Securities Law Violations - Investors Should Contact Levi & Korsinsky Before October 14, 2025 to Discuss Your Rights - UNCY - Sahm

Unicycive Therapeutics, Inc. Sued for Securities Law Violations - Investors Should Contact Levi & Korsinsky Before October 14, 2025 to Discuss Your Rights - UNCY  Sahm

Unicycive Therapeutics, Inc. Sued for Securities Law Violations - Investors Should Contact Levi & Korsinsky Before October 14, 2025 to Discuss Your Rights - UNCY - Sahm

Click here to get full coverage on Unicycive Therapeutics, Inc. Announces Reverse Stock Split - GlobeNewswire

Unicycive Therapeutics, Inc. Announces Reverse Stock Split  GlobeNewswire

Unicycive Therapeutics, Inc. Announces Reverse Stock Split - GlobeNewswire

Click here to get full coverage on Lost Money on Unicycive Therapeutics, Inc.(UNCY)? Join Class Act - GuruFocus

Lost Money on Unicycive Therapeutics, Inc.(UNCY)? Join Class Act  GuruFocus

Lost Money on Unicycive Therapeutics, Inc.(UNCY)? Join Class Act - GuruFocus

Click here to get full coverage on Unicycive Therapeutics Regains Compliance with Nasdaq Minimum Bid Price Requirement - Yahoo Finance

Unicycive Therapeutics Regains Compliance with Nasdaq Minimum Bid Price Requirement  Yahoo Finance

Unicycive Therapeutics Regains Compliance with Nasdaq Minimum Bid Price Requirement - Yahoo Finance

Click here to get full coverage on Unicycive Therapeutics Announces 1-for-10 Reverse Stock Split to Comply with Nasdaq Listing Requirements - Nasdaq

Unicycive Therapeutics Announces 1-for-10 Reverse Stock Split to Comply with Nasdaq Listing Requirements  Nasdaq

Unicycive Therapeutics Announces 1-for-10 Reverse Stock Split to Comply with Nasdaq Listing Requirements - Nasdaq

Click here to get full coverage on Unicycive Therapeutics Announces Receipt of Complete - GlobeNewswire

Unicycive Therapeutics Announces Receipt of Complete  GlobeNewswire

Unicycive Therapeutics Announces Receipt of Complete - GlobeNewswire

Click here to get full coverage on Lost Money on Unicycive Therapeutics, Inc. (UNCY)? Urged to Join Class Action Before October 14, 2025 - Contact Levi & Korsinsky - ACCESS Newswire

Lost Money on Unicycive Therapeutics, Inc. (UNCY)? Urged to Join Class Action Before October 14, 2025 - Contact Levi & Korsinsky  ACCESS Newswire

Lost Money on Unicycive Therapeutics, Inc. (UNCY)? Urged to Join Class Action Before October 14, 2025 - Contact Levi & Korsinsky - ACCESS Newswire

Click here to get full coverage on Update Recap: Whats the MACD signal for UNCY - 2026 Pullback Review & Accurate Buy Signal Alerts - baoquankhu1.vn

Update Recap: Whats the MACD signal for UNCY - 2026 Pullback Review & Accurate Buy Signal Alerts  baoquankhu1.vn

Update Recap: Whats the MACD signal for UNCY - 2026 Pullback Review & Accurate Buy Signal Alerts - baoquankhu1.vn

Click here to get full coverage on Unicycive Therapeutics to Participate in a Fireside Chat at Guggenheim’s Emerging Outlook: Biotech Summit - GlobeNewswire

Unicycive Therapeutics to Participate in a Fireside Chat at Guggenheim’s Emerging Outlook: Biotech Summit  GlobeNewswire

Unicycive Therapeutics to Participate in a Fireside Chat at Guggenheim’s Emerging Outlook: Biotech Summit - GlobeNewswire

Click here to get full coverage on Important Notice to Long-Term Shareholders of Applied - GlobeNewswire

Important Notice to Long-Term Shareholders of Applied  GlobeNewswire

Important Notice to Long-Term Shareholders of Applied - GlobeNewswire

Click here to get full coverage on Pomerantz Law Firm Announces the Filing of a Class Action Against Unicycive Therapeutics, Inc. and Certain Officers - UNCY - Finansavisen

Pomerantz Law Firm Announces the Filing of a Class Action Against Unicycive Therapeutics, Inc. and Certain Officers - UNCY  Finansavisen

Pomerantz Law Firm Announces the Filing of a Class Action Against Unicycive Therapeutics, Inc. and Certain Officers - UNCY - Finansavisen

Click here to get full coverage on FDA rejects South Bay drugmaker Unicycive's tablets for dialysis patients due to vendor problem - The Business Journals

FDA rejects South Bay drugmaker Unicycive's tablets for dialysis patients due to vendor problem  The Business Journals

FDA rejects South Bay drugmaker Unicycive's tablets for dialysis patients due to vendor problem - The Business Journals

Click here to get full coverage on ROSEN, LEADING INVESTOR COUNSEL, Encourages Unicycive - GlobeNewswire

ROSEN, LEADING INVESTOR COUNSEL, Encourages Unicycive  GlobeNewswire

ROSEN, LEADING INVESTOR COUNSEL, Encourages Unicycive - GlobeNewswire

Click here to get full coverage on Levi & Korsinsky Notifies Unicycive Therapeutics, Inc. - GlobeNewswire

Levi & Korsinsky Notifies Unicycive Therapeutics, Inc.  GlobeNewswire

Levi & Korsinsky Notifies Unicycive Therapeutics, Inc. - GlobeNewswire

Click here to get full coverage on UNCY Forecast — Price Prediction for 2026. Should I Buy UNCY? - Intellectia AI

UNCY Forecast — Price Prediction for 2026. Should I Buy UNCY?  Intellectia AI

UNCY Forecast — Price Prediction for 2026. Should I Buy UNCY? - Intellectia AI

Click here to get full coverage on Unicycive Therapeutics Provides Update from FDA Type A - GlobeNewswire

Unicycive Therapeutics Provides Update from FDA Type A  GlobeNewswire

Unicycive Therapeutics Provides Update from FDA Type A - GlobeNewswire

Click here to get full coverage on Piper Sandler highlights commercial biotech names to own in 2026 - Investing.com

Piper Sandler highlights commercial biotech names to own in 2026  Investing.com

Piper Sandler highlights commercial biotech names to own in 2026 - Investing.com

Click here to get full coverage on Unicycive Therapeutics, Inc. Sued for Securities Law - GlobeNewswire

Unicycive Therapeutics, Inc. Sued for Securities Law  GlobeNewswire

Unicycive Therapeutics, Inc. Sued for Securities Law - GlobeNewswire

Click here to get full coverage on Bragar Eagel & Squire, P.C. Reminds Investors of Unicycive, - GlobeNewswire

Bragar Eagel & Squire, P.C. Reminds Investors of Unicycive,  GlobeNewswire

Bragar Eagel & Squire, P.C. Reminds Investors of Unicycive, - GlobeNewswire

Click here to get full coverage on Unicycive stock rises after FDA accepts OLC drug application resubmission - Investing.com

Unicycive stock rises after FDA accepts OLC drug application resubmission  Investing.com

Unicycive stock rises after FDA accepts OLC drug application resubmission - Investing.com

Click here to get full coverage on FinancialContent - INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Unicycive Therapeutics, Inc. - UNCY - FinancialContent

FinancialContent - INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Unicycive Therapeutics, Inc. - UNCY  FinancialContent

FinancialContent - INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Unicycive Therapeutics, Inc. - UNCY - FinancialContent

Click here to get full coverage on Bragar Eagel & Squire is Investigating Certain Officers and Directors of Quantum, Unicycive, Fly-E, and Lantheus on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm - GlobeNewswire

Bragar Eagel & Squire is Investigating Certain Officers and Directors of Quantum, Unicycive, Fly-E, and Lantheus on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm  GlobeNewswire

Bragar Eagel & Squire is Investigating Certain Officers and Directors of Quantum, Unicycive, Fly-E, and Lantheus on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm - GlobeNewswire

Click here to get full coverage on Unicycive Therapeutics Announces Full Year 2024 Financial Results and Provides Business Update - GlobeNewswire

Unicycive Therapeutics Announces Full Year 2024 Financial Results and Provides Business Update  GlobeNewswire

Unicycive Therapeutics Announces Full Year 2024 Financial Results and Provides Business Update - GlobeNewswire

Click here to get full coverage on Here's Why We're Watching Unicycive Therapeutics' (NASDAQ:UNCY) Cash Burn Situation - Yahoo Finance

Here's Why We're Watching Unicycive Therapeutics' (NASDAQ:UNCY) Cash Burn Situation  Yahoo Finance

Here's Why We're Watching Unicycive Therapeutics' (NASDAQ:UNCY) Cash Burn Situation - Yahoo Finance

Click here to get full coverage on When Can We Expect A Profit From Unicycive Therapeutics, Inc. (NASDAQ:UNCY)? - Yahoo Finance

When Can We Expect A Profit From Unicycive Therapeutics, Inc. (NASDAQ:UNCY)?  Yahoo Finance

When Can We Expect A Profit From Unicycive Therapeutics, Inc. (NASDAQ:UNCY)? - Yahoo Finance

Click here to get full coverage on UNCY Stock Price and Chart — NASDAQ:UNCY - TradingView

UNCY Stock Price and Chart — NASDAQ:UNCY  TradingView

UNCY Stock Price and Chart — NASDAQ:UNCY - TradingView

Click here to get full coverage on Unicycive's OLC Drug Gets FDA Review Date, Reports Strong Q3 Pipeline Progress - Stock Titan

Unicycive's OLC Drug Gets FDA Review Date, Reports Strong Q3 Pipeline Progress  Stock Titan

UNCY

Price Chart

Key Statistics

Technicals

About UNCY

Latest News

FDA sets June 27 action date for Unicycive kidney disease pill - Stock Titan

Unicycive Therapeutics, Inc. (UNCY) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Stockholders to Contact the Firm to Learn More About the Investigation - ACCESS Newswire

Companies Like Unicycive Therapeutics (NASDAQ:UNCY) Are In A Position To Invest In Growth - Yahoo Finance

Advanced Charts

Top Gainers

Top Losers